Associate Professor of Dermatology, University of Massachusetts Medical School
Dr. Harris is a tenure-track Assistant Professor in the Dermatology Division, Department of Medicine at the University of Massachusetts Medical School (UMMS) in Worcester, MA. Dr. Harris directs the Vitiligo Clinic and Research Center at UMMS, which incorporates a specialty clinic for the diagnosis and treatment of patients with vitiligo, as well as a vitiligo research laboratory. He uses basic, translational, and clinical research approaches to better understand autoimmunity in vitiligo, with a particular focus on developing more effective treatments.
He earned his MD and PhD degrees at UMMS, and his PhD thesis was focused on the loss of autoimmune tolerance in juvenile diabetes. He entered a combined research/residency program in dermatology at the University of Pennsylvania in Philadelphia, PA, and his postdoctoral research focused on the development of a mouse model of vitiligo with epidermal depigmentation. He now advises multiple graduate students, MD/PhD students, and postdoctoral fellows in his research laboratory at UMMS, and teaches medical students and residents in his vitiligo clinic.
He has authored multiple research publications and textbook chapters on vitiligo and other topics, and serves on a number of advisory boards and committees, including the Dermatology Foundation, Skin of Color Society, Vitiligo Working Group, Vitiligo Research Foundation, National Alopecia Areata Foundation, American Academy of Dermatology and the New England Dermatology Society, among others. He is an advisor and collaborator with multiple pharmaceutical companies, including AbbVie, Combe Inc, Genzyme/Sanofi, and Pfizer.
Dr. Harris is an ad hoc reviewer on grant applications for the National Institutes of Health (NIH), Dermatology Foundation, and National Alopecia Areata Foundation, as well as multiple research journals, including Science Translational Medicine, the Journal of Clinical Investigation, the Journal of Investigative Dermatology, Pigment Cell & Melanoma Research, Experimental Dermatology, the Journal of the American Academy of Dermatology, JAMA Dermatology, and others. He receives generous grant support from the NIH, Dermatology Foundation, Kawaja Vitiligo Initiative, and the Vitiligo Research Foundation. He has lectured on vitiligo and other topics to local, regional, national, and international audiences.
Education
Postdoctoral Fellowship, University of Pennsylvania, Philadelphia, PA
Research: “Development of a Mouse Model to Study Vitiligo Pathogenesis”
Advisors: Dr. Laurence Turka, Dr. John Wherry, Dr. Christopher Hunter
Dermatology Residency, University of Pennsylvania, Philadelphia, PA
Medical Internship, UMass Medical School, Worcester, MA
Ph.D., (Molecular Medicine), UMass Medical School, Worcester, MA
Thesis Title: “The Molecular Mechanisms of T cell Clonal Anergy”
Advisors: Dr. Aldo Rossini, Dr. Michael Czech
M.D., UMass Medical School, Worcester, MA
B.S., Premedicine, Gordon College, Wenham, MA
Membership in Vitiligo Societies:
Co-founder and Board Member, Vitiligo Working Group
Member Scientific Committee, Skin of Color Society
Board Member, Skin of Color Society
Basic Research Advisory Council, National Alopecia Areata Foundation
Scientific Advisory Board, Vitiligo Research Foundation
Board Member, New England Dermatology Society
Medical and Scientific Committee, Dermatology Foundation
Fellow, American Academy of Dermatology
New treatment in the works for disfiguring skin disease, vitiligo
Jul 19, 2018 14:35 pm UTC| Insights & Views Health
In many parts of the world there is great shame and stigma tied to vitiligo, an autoimmune disease of the skin that causes disfiguring white spots, which can appear anywhere on the body. In some societies, individuals with...
There’s an extra $1 billion on the table for NT schools. This could change lives if spent well
Political donations rules are finally in the spotlight – here’s what the government should do